KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Return on Sales (2020 - 2025)

Organon has reported Return on Sales over the past 6 years, most recently at 0.14% for Q4 2025.

  • Quarterly results put Return on Sales at 0.14% for Q4 2025, down 20.0% from a year ago — trailing twelve months through Dec 2025 was 0.03% (down 10.0% YoY), and the annual figure for FY2025 was 0.03%, down 10.0%.
  • Return on Sales for Q4 2025 was 0.14% at Organon, down from 0.1% in the prior quarter.
  • Over the last five years, Return on Sales for OGN hit a ceiling of 0.34% in Q4 2023 and a floor of 0.14% in Q4 2025.
  • Median Return on Sales over the past 5 years was 0.08% (2024), compared with a mean of 0.08%.
  • Peak annual rise in Return on Sales hit 19bps in 2024, while the deepest fall reached -27bps in 2024.
  • Organon's Return on Sales stood at 0.0% in 2021, then skyrocketed by 50bps to 0.0% in 2022, then surged by 54469bps to 0.34% in 2023, then tumbled by -80bps to 0.07% in 2024, then plummeted by -299bps to 0.14% in 2025.
  • The last three reported values for Return on Sales were 0.14% (Q4 2025), 0.1% (Q3 2025), and 0.09% (Q2 2025) per Business Quant data.